Skip to main content
. 2022 Apr 29;6(24):6162–6168. doi: 10.1182/bloodadvances.2022007031

Table 4.

Comparison of XmnI polymorphism with respect to the outcome (n = 133)

XmnI Overall n (%) Good responder (n = 88) n (%) Responder (n = 15) n (%) Nonresponder (n = 30) n (%)
Positive/positive 11 (8.3) 6 (6.8) 0 (0) 5 (16.7)
Negative/negative 108 (81.2) 72 (81.8) 13 (86.7) 23 (76.7)
Positive/negative 14 (10.5) 10 (11.4) 2 (13.3) 2 (6.7)